Literature DB >> 15767417

Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.

Sook-Kyung Lee1, Kunio Nagashima, Wei-Shau Hu.   

Abstract

The Gag polyprotein of murine leukemia virus (MLV) is processed into matrix (MA), p12, capsid (CA), and nucleocapsid (NC) proteins. p12 affects early events of virus replication and contains a PPPY motif important for virus release. To probe the functions of p12 in the early steps of MLV replication, we tested whether p12 can be replaced by spleen necrosis virus (SNV) p18, human immunodeficiency virus type 1 p6, or Rous sarcoma virus p2b. Analyses revealed that all chimeras generated virions at levels similar to that of MLV gag-pol; however, none of them could support MLV vector replication, and all of them exhibited severely reduced DNA synthesis upon virus infection. Because a previously reported SNV gag-MLV pol chimera, but not the MLV hybrid with SNV p18, can support replication of an MLV vector, we hypothesized that other Gag proteins act cooperatively with p12 during the early phase of virus replication. To test this hypothesis, we generated three more MLV-based chimeras containing SNV CA, p18-CA, or p18-CA-NC. We found that the MLV chimera containing SNV p18-CA or p18-CA-NC could support MLV vector replication, but the chimera containing SNV CA could not. Furthermore, viruses derived from the MLV chimera with SNV CA could synthesize viral DNA upon infection but were blocked at a post-reverse-transcription step and generated very little two long terminal repeat circle DNA, thereby producing a phenotype similar to that of the provirus formation-defective p12 mutants. Taken together, our data indicate that when p12/p18 or CA was from different viruses, despite abundant virus production and proper Gag processing, the resulting viruses were not infectious. However, when p12/p18 and CA were from the same virus, even though they were from SNV and not MLV, the resulting viruses were infectious. Therefore, these results suggest a cooperative effect of p12 and CA during the early events of MLV replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767417      PMCID: PMC1061564          DOI: 10.1128/JVI.79.7.4159-4169.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication.

Authors:  S R Cheslock; J A Anderson; C K Hwang; V K Pathak; W S Hu
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

2.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function.

Authors:  Dimiter G Demirov; Akira Ono; Jan M Orenstein; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.

Authors:  B Yuan; S Campbell; E Bacharach; A Rein; S P Goff
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus.

Authors:  R J Gorelick; W Fu; T D Gagliardi; W J Bosche; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.

Authors:  J L Certo; T O Kabdulov; M L Paulson; J A Anderson; W S Hu
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

8.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

9.  In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.

Authors:  S Campbell; A Rein
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Zinc finger domain of murine leukemia virus nucleocapsid protein enhances the rate of viral DNA synthesis in vivo.

Authors:  Wen-Hui Zhang; Carey K Hwang; Wei-Shau Hu; Robert J Gorelick; Vinay K Pathak
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more
  15 in total

1.  Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.

Authors:  Tobias Paprotka; Narasimhan J Venkatachari; Chawaree Chaipan; Ryan Burdick; Krista A Delviks-Frankenberry; Wei-Shau Hu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  High-throughput, library-based selection of a murine leukemia virus variant to infect nondividing cells.

Authors:  Julie H Yu; David V Schaffer
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Higher-order structure of the Rous sarcoma virus SP assembly domain.

Authors:  Di L Bush; Eric B Monroe; Gregory J Bedwell; Peter E Prevelige; Judith M Phillips; Volker M Vogt
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

4.  Phosphorylation Requirement of Murine Leukemia Virus p12.

Authors:  Jonathon D Brzezinski; Roland Felkner; Apexa Modi; Mengdan Liu; Monica J Roth
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

5.  Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.

Authors:  Andrew Yueh; Juliana Leung; Subarna Bhattacharyya; Lucy A Perrone; Kenia de los Santos; Szy-Yuan Pu; Stephen P Goff
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins.

Authors:  Sook-Kyung Lee; Vitaly Boyko; Wei-Shau Hu
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

7.  The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex.

Authors:  Adi Prizan-Ravid; Efrat Elis; Nihay Laham-Karam; Sara Selig; Marcelo Ehrlich; Eran Bacharach
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

8.  Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.

Authors:  Paul W Keller; Marc C Johnson; Volker M Vogt
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

9.  p12 tethers the murine leukemia virus pre-integration complex to mitotic chromosomes.

Authors:  Efrat Elis; Marcelo Ehrlich; Adi Prizan-Ravid; Nihay Laham-Karam; Eran Bacharach
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

10.  The gammaretroviral p12 protein has multiple domains that function during the early stages of replication.

Authors:  Darren J Wight; Virginie C Boucherit; Mirella Nader; David J Allen; Ian A Taylor; Kate N Bishop
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.